SQI Diagnostics announces agreement with Isis Pharmaceuticals

theflyonthewall.com

SQI Diagnostics announced that they have entered into a method development agreement with Isis Pharmaceuticals to develop a multiplexed assay that will utilize SQI’s Ig_PLEX multiplexing immunogenicity technology.

Rates

View Comments (0)